Blue Clay Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Blue Clay Capital Management’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.75M	Buy
2016 Q2	$1.92M	Sell
2016 Q1	$1.89M	Sell
2015 Q4	$2.19M	Sell
2015 Q3	$1.9M	Sell
2015 Q2	$2.59M	Sell
2015 Q1	$2.83M	Sell
2014 Q4	$2.21M	Buy